Volumetric dried blood microsampling for monitoring imatinib mesylate therapy: Method development and clinical application in patients with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Volumetric dried blood microsampling for monitoring imatinib mesylate therapy: Method development and clinical application in patients with chronic myeloid leukemia

Published:2023-01 Issue: Volume:222 Page:115108
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Krützmann Maria Eduarda,Martini Ranieri Reichel,de Souza Guterres Fernanda,Kohlrausch Ramona,Wagner Sandrine Comparsi,Mattevi Vanessa Suñe,Torriani Mayde Seadi,Fogliatto Laura Maria,Linden Rafael,Antunes Marina Venzon

Funder

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference27 articles.

1. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy;Soverini;Mol. Cancer,2018

2. Novartis pharma produktions GMBH, WEHR, Alemanha. Gilvec®. Imatinibe. VPS23: Glivec Bula Profissional, (2019).

3. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles;Di Gion;Clin. Pharmacokinet.,2011

4. Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy;Angelini;Haematologica,2013

5. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes;Nebot;Br. J. Pharmacol.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites;Therapeutic Drug Monitoring;2024-01-30

2. THE SIMULTANEOUS QUANTIFICATION OF RIFAMPICIN AND ISONIAZID IN PATIENTS WITH TUBERCULOSIS APPLIED TO VOLUMETRIC ABSORPTIVE MICROSAMPLING DEVICES USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;International Journal of Applied Pharmaceutics;2024-01-07

3. Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation;Pharmacogenomics;2023-12

4. Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy;International Journal of Biological Macromolecules;2023-08

5. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities;Expert Review of Clinical Pharmacology;2023-06-12